Beacon NewsFlashes – March 11, 2013 – The Myeloma Beacon
Beacon NewsFlashes – March 11, 2013
The Myeloma Beacon Treanda May Enhance Response To Stem Cell Transplant In Myeloma Patients – Results from a Phase 1 clinical trial demonstrate the safety of adding Treanda (bendamustine) to melphalan (Alkeran) as high-dose therapy prior to stem cell transplantation. |